Found: 16
Select item for more details and to access through your institution.
A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.887298
- By:
- Publication type:
- Article
Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia ( DR- CLL).
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 449, doi. 10.1111/bjh.13224
- By:
- Publication type:
- Article
Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0136207
- By:
- Publication type:
- Article
Health technology assessment of tests for SARSCoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000223
- By:
- Publication type:
- Article
Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Challenges in synthesising cost-effectiveness estimates.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 604, doi. 10.1002/cpt.2977
- By:
- Publication type:
- Article
Living Health Technology Assessment: Issues, Challenges and Opportunities.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 227, doi. 10.1007/s40273-022-01229-4
- By:
- Publication type:
- Article
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 3, p. 249, doi. 10.1007/s40273-021-01116-4
- By:
- Publication type:
- Article
Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable Workshop.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 12, p. 1455, doi. 10.1007/s40273-021-01097-4
- By:
- Publication type:
- Article
Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme.
- Published in:
- Programme Grants for Applied Research (PGfAR), 2022, v. 10, n. 3, p. vii, doi. 10.3310/lvuq5853
- By:
- Publication type:
- Article
Identifying and managing psoriasisassociated comorbidities: the IMPACT research programme.
- Published in:
- Programme Grants for Applied Research (PGfAR), 2022, p. i, doi. 10.3310/LVUQ5853
- By:
- Publication type:
- Article
Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1289365
- By:
- Publication type:
- Article
Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1291164
- By:
- Publication type:
- Article
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 5, p. 554, doi. 10.3109/0284186X.2015.1096021
- By:
- Publication type:
- Article